Interventional Radiology Products Market : An Emerging Market with Attractive Growth Opportunities

By -

Interventional Radiology Products Market by type (Stents, Catheters, IVC Filter, Accessories), Procedure Type (Angioplasty, Angiography, Biopsy, Thrombolysis, Embolization), Applications (Oncology, Cardiology, Urology & Nephrology) - Forecast to 2021

(EMAILWIRE.COM, August 22, 2019 ) Globally, the interventional radiology products market is witnessing moderate growth due to factors such as rising incidence of chronic diseases, rising geriatric population, and increasing demand for minimally invasive surgeries.

On the other hand, availability of cost-effective conventional first-level treatments and product failures and recalls are the key restraining factors to the growth of this market. The high growth potential in the emerging regions like Asia provides growth opportunities for players operating in the interventional radiology products market.

Based on type, the interventional radiology products market is segmented into stents, catheters, IVC filters, hemodynamic flow alteration devices, angioplasty balloons, thrombectomy systems, embolization devices, biopsy needles, and accessories. In 2016, the stents segment is expected to account for the largest share of the market. The key factors driving the growth of the interventional radiology stents market are the growing geriatric population and increasing incidence of cardiovascular diseases around the world.

Based on procedure, the interventional radiology products market is segmented into angioplasty, angiography, embolization, thrombolysis, biopsy & drainage, vertebroplasty, nephrostomy, and other procedures. In 2016, the angiography segment is expected to account for the largest share of the market. The increasing prevalence of these conditions and the growing demand for minimally invasive procedures are the key factors driving market growth in this segment.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=67681703

Based on application, the market is segmented into cardiology, urology & nephrology, oncology, gastroenterology, neurology, orthopedics, and other applications. The oncology segment is expected to grow at the highest CAGR during the forecast period. The major factors driving the growth of this market segment are the increasing incidence of cancer and rising demand for minimally invasive procedures.

Based on region, the interventional radiology products market is segmented into North America, Europe, Asia and Rest of the World (RoW). In 2016, North America is expected to dominate the interventional radiology products market while Asia is expected to grow at the highest CAGR during the forecast period. The high growth of this geographic segment is attributed to the increasing prevalence of chronic diseases and growing geriatric population in Asia. The market is further driven by factors such as increasing reimbursement for minimally invasive procedures.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=67681703

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more